Abridge Doubles Valuation to $5.3B in Just Four Months

Abridge, a healthcare AI startup that automates medical documentation, has raised $300 million in a Series E funding round, pushing its valuation to $5.3 billion, according to the Wall Street Journal. The round was led by Andreessen Horowitz, with participation from Khosla Ventures, and comes just four months after Abridge secured $250 million at a $2.75 billion valuation.

Founded seven years ago, Abridge has emerged as a frontrunner in the competitive market for AI-driven medical scribe solutions. Its early start and strategic partnership with Epic Systems, a leading electronic health record provider, have helped cement its leadership.

According to The Information, Abridge reported $117 million in contracted annual recurring revenue in the first quarter of the year. This figure includes all signed recurring contracts, even those from clients who have not yet fully launched the service.

In addition to the new funding, Abridge also announced it is expanding its services to include the automatic generation of medical billing codes from clinical notes — positioning it to compete directly with companies like CodaMetrix, as well as similar functionality offered by Epic Systems.

The company, founded by cardiologist Dr. Shiv Rao, says its AI scribing technology is now in use across more than 150 major health systems in the United States.